Model Number VTICMO12.6 |
Device Problems
Misfocusing (1401); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Macular Edema (1822); Inflammation (1932); Blurred Vision (2137); No Code Available (3191)
|
Event Date 07/18/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
This product is not marketed in the us.(b)(4).
|
|
Event Description
|
The reporter indicated that the surgeon implanted a 12.6 mm vticmo12.6, implantable collamer lens in the patient's left eye (os) on (b)(6) 2018.Lens was explanted on (b)(6) 2018 due to loss of bcva (post-op bcva 20/50) and cystoid macular edema.Antibiotics and anti-inflammatories were used to address inflammation.No infection occured.It was reported that the explant resolved the problem.Patient ok after edema adsorption.No plans to implant an icl lens.
|
|
Manufacturer Narrative
|
Additional data: device evaluation: the lens was returned dry, in a micro-centrifuge vial.There was clear surgical residue on the product and lens surface.Visual inspection found no visible damage to the lens.Corrected data: work order search: no similar complaint type events reported for units within the same lot - is added to initial mdr.(b)(4).
|
|
Manufacturer Narrative
|
Corrected data: the reporter indicated that the surgeon implanted a 12.6 mm vticmo12.6, -15/+0.5/038 (sphere/cylinder/axis), implantable collamer lens in the patient's left eye (os) on (b)(6) 2017.Lens was explanted on (b)(6) 2018 due to loss of bcva (post-op bcva 20/50) and cystoid macular edema.Antibiotics and anti-inflammatories were used to address inflammation.No infection occurred.It was reported that the explant resolved the problem.Patient ok after edema adsorption.No plans to implant an icl lens.(b)(4).
|
|
Search Alerts/Recalls
|